Influence of diabetes mellitus on dapagliflozin response after transcatheter aortic valve replacement (TAVR): insights from the DAPA-TAVI trial.

Párraga R, Real C, Nombela-Franco L, Amat-Santos I, Jimenez-Quevedo P, Otero DL, Gheorghe L, Sanz-Sánchez J, Zorita CB, Ojeda S, Ferreiro RG, García AJM, Vilalta V, Fernández GV, Soriano JGC, Cepas-Guillén P, Rollán MS, Ríos XF, Palma-Carbajal R, Reyes RM, Romaguera R, Avanzas P, Blas SG, Franco-Peláez JA, Moreiras JM, González-Juanatey JR, Calle G, Díez JL, Santos-Martínez S, Erquicia PD, García EM, Fernandez-Nofrerias E, Sanmartín X, Barrios AG, Bermúdez IG, Fuster V, Ibáñez B, Roubín SR

Open source

DOI: 10.1186/s12933-026-03297-8
Published: 2026 Aug 10
Container: Cardiovascular diabetology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12933-026-03297-8,
  title = {Influence of diabetes mellitus on dapagliflozin response after transcatheter aortic valve replacement (TAVR): insights from the DAPA-TAVI trial.},
  author = {Párraga R and Real C and Nombela-Franco L and Amat-Santos I and Jimenez-Quevedo P and Otero DL and Gheorghe L and Sanz-Sánchez J and Zorita CB and Ojeda S and Ferreiro RG and García AJM and Vilalta V and Fernández GV and Soriano JGC and Cepas-Guillén P and Rollán MS and Ríos XF and Palma-Carbajal R and Reyes RM and Romaguera R and Avanzas P and Blas SG and Franco-Peláez JA and Moreiras JM and González-Juanatey JR and Calle G and Díez JL and Santos-Martínez S and Erquicia PD and García EM and Fernandez-Nofrerias E and Sanmartín X and Barrios AG and Bermúdez IG and Fuster V and Ibáñez B and Roubín SR},
  year = {2026},
  journal = {Cardiovascular diabetology},
  doi = {10.1186/s12933-026-03297-8},
  url = {https://doi.org/10.1186/s12933-026-03297-8}
}

RIS

TY  - JOUR
TI  - Influence of diabetes mellitus on dapagliflozin response after transcatheter aortic valve replacement (TAVR): insights from the DAPA-TAVI trial.
AU  - Párraga R
AU  - Real C
AU  - Nombela-Franco L
AU  - Amat-Santos I
AU  - Jimenez-Quevedo P
AU  - Otero DL
AU  - Gheorghe L
AU  - Sanz-Sánchez J
AU  - Zorita CB
AU  - Ojeda S
AU  - Ferreiro RG
AU  - García AJM
AU  - Vilalta V
AU  - Fernández GV
AU  - Soriano JGC
AU  - Cepas-Guillén P
AU  - Rollán MS
AU  - Ríos XF
AU  - Palma-Carbajal R
AU  - Reyes RM
AU  - Romaguera R
AU  - Avanzas P
AU  - Blas SG
AU  - Franco-Peláez JA
AU  - Moreiras JM
AU  - González-Juanatey JR
AU  - Calle G
AU  - Díez JL
AU  - Santos-Martínez S
AU  - Erquicia PD
AU  - García EM
AU  - Fernandez-Nofrerias E
AU  - Sanmartín X
AU  - Barrios AG
AU  - Bermúdez IG
AU  - Fuster V
AU  - Ibáñez B
AU  - Roubín SR
PY  - 2026
JO  - Cardiovascular diabetology
DO  - 10.1186/s12933-026-03297-8
UR  - https://doi.org/10.1186/s12933-026-03297-8
ER  -

APA

R, P., C, R., L, N., I, A., P, J., DL, O., L, G., J, S., CB, Z., S, O., RG, F., AJM, G., V, V., GV, F., JGC, S., P, C., MS, R., XF, R., R, P., RM, R., R, R., P, A., SG, B., JA, F., JM, M., JR, G., G, C., JL, D., S, S., PD, E., EM, G., E, F., X, S., AG, B., IG, B., V, F., B, I., & SR, R. (2026). Influence of diabetes mellitus on dapagliflozin response after transcatheter aortic valve replacement (TAVR): insights from the DAPA-TAVI trial.. Cardiovascular diabetology. https://doi.org/10.1186/s12933-026-03297-8

Source records

pubmed · retrieved 2026-11-10T18:05:35.003Z